Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-22-037954

Director acquired 1,574 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ainsworth Sean Director 2022-10-19 Option exercise +1,574 $0.00 $0 41,239 D
Derivatives
Ainsworth Sean Director 2022-10-19 Option exercise · Series B Warrant (right to buy) −1,574 0 D
Loading xslF345X03/form4.xml…